» Articles » PMID: 21031580

Recombinant Osteopontin in Cerebral Vasospasm After Subarachnoid Hemorrhage

Overview
Journal Ann Neurol
Specialty Neurology
Date 2010 Oct 30
PMID 21031580
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Osteopontin (OPN), a pleiotropic extracellular matrix glycoprotein, has been reported to be protective against ischemic lesions, but effects of OPN on vascular functions have not been investigated. The aim of this study was to assess whether recombinant OPN (r-OPN) could prevent cerebral vasospasm after subarachnoid hemorrhage (SAH) in rats.

Methods: r-OPN was administered intraventricularly to rats undergoing SAH by endovascular perforation, and its protective effects were evaluated by measuring the diameter of cerebral arteries and neurobehavioral testing. Western blotting and immunofluorescence were performed to explore the underlying mechanisms. An integrin receptor antagonist GRGDSP or mitogen-activated protein kinase (MAPK) phosphatase (MKP)-1 small interfering RNA (siRNA) was also administered to r-OPN-treated SAH rats, and those effects were evaluated.

Results: Pre-SAH administration of r-OPN prevented vasospasm and neurological impairments at 24-72 hours post-SAH. r-OPN enhanced an endogenous MAPK inhibitor, MKP-1, and suppressed the phosphorylation of MAPKs, caldesmon, and heat shock protein 27 in the spastic cerebral arteries at 24 hours post-SAH. Immunofluorescence revealed that MKP-1 was induced in the arterial smooth muscle layer. GRGDSP prevented r-OPN-induced MKP-1 upregulation, and MKP-1 siRNA abolished both MAPK inactivation and anti-vasospastic effects by r-OPN. Post-SAH r-OPN treatment also prevented vasospasm.

Interpretation: r-OPN induced MKP-1 in the spastic cerebral arteries via binding to L-arginyl-glycyl-L-aspartate-dependent integrin receptors and prevented vasospasm after SAH. Therapeutic induction of MKP-1 may be a novel approach for the prevention and treatment of cerebral vasospasm.

Citing Articles

Huperzine A ameliorates neurological deficits after spontaneous subarachnoid hemorrhage through endothelial cell pyroptosis inhibition.

Hu Q, Zhang R, Dong X, Yang D, Yu W, Du Q Acta Biochim Biophys Sin (Shanghai). 2024; 56(4):645-656.

PMID: 38529553 PMC: 11090845. DOI: 10.3724/abbs.2024037.


Acute-Phase Plasma Pigment Epithelium-Derived Factor Predicting Outcomes after Aneurysmal Subarachnoid Hemorrhage in the Elderly.

Nampei M, Suzuki Y, Nakajima H, Oinaka H, Kawakita F, Suzuki H Int J Mol Sci. 2024; 25(3).

PMID: 38338974 PMC: 10855834. DOI: 10.3390/ijms25031701.


Circulating Extracellular Vesicles in Subarachnoid Hemorrhage Patients: Characterization and Cellular Effects.

Grossini E, Esposito T, Viretto M, Venkatesan S, Licari I, Surico D Int J Mol Sci. 2023; 24(19).

PMID: 37834361 PMC: 10573706. DOI: 10.3390/ijms241914913.


Pretreatment with Clodronate Improved Neurological Function by Preventing Reduction of Posthemorrhagic Cerebral Blood Flow in Experimental Subarachnoid Hemorrhage.

Uchikawa H, Kameno K, Kai K, Kajiwara S, Fujimori K, Uekawa K Neurocrit Care. 2023; 39(1):207-217.

PMID: 37308726 DOI: 10.1007/s12028-023-01754-w.


Compartmental Cerebrospinal Fluid Events Occurring after Subarachnoid Hemorrhage: An "Heparin Oriented" Systematic Review.

Tartara F, Montalbetti A, Crobeddu E, Armocida D, Tavazzi E, Cardia A Int J Mol Sci. 2023; 24(9).

PMID: 37175544 PMC: 10178276. DOI: 10.3390/ijms24097832.


References
1.
Boutros T, Chevet E, Metrakos P . Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev. 2008; 60(3):261-310. DOI: 10.1124/pr.107.00106. View

2.
Guo H, Wai P, Mi Z, Gao C, Zhang J, Kuo P . Osteopontin mediates Stat1 degradation to inhibit iNOS transcription in a cecal ligation and puncture model of sepsis. Surgery. 2008; 144(2):182-8. PMC: 2525867. DOI: 10.1016/j.surg.2008.03.007. View

3.
Keyse S . Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 2008; 27(2):253-61. DOI: 10.1007/s10555-008-9123-1. View

4.
Suzuki H, Hasegawa Y, Kanamaru K, Zhang J . Mitogen-activated protein kinases in cerebral vasospasm after subarachnoid hemorrhage: a review. Acta Neurochir Suppl. 2010; 110(Pt 1):133-9. DOI: 10.1007/978-3-7091-0353-1_23. View

5.
Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F . Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa.... J Neurosurg. 2005; 103(1):9-17. DOI: 10.3171/jns.2005.103.1.0009. View